Clinical trial
Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)
NCT05111301 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2021
- Completion date
- August 18, 2022
- Enrollment
- 30 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes treated with insulin